Bevacizumab suppression of establishment of micrometastases in experimental ocular melanoma
- PMID: 21123801
- PMCID: PMC3055783
- DOI: 10.1167/iovs.10-6275
Bevacizumab suppression of establishment of micrometastases in experimental ocular melanoma
Comment on
-
Bevacizumab suppression of establishment of micrometastases in experimental ocular melanoma.Invest Ophthalmol Vis Sci. 2010 Jun;51(6):2835-42. doi: 10.1167/iovs.09-4755. Epub 2010 Jan 20. Invest Ophthalmol Vis Sci. 2010. PMID: 20089875 Free PMC article.
References
-
- Sharma HS, Tang ZH, Gho BCG, Verdouw PD. Nucleotide sequence and expression of the porcine vascular endothelial growth factor. Biochim Biophys Acta. 1995;1260:235–238 - PubMed
-
- National Library of Medicine Medical Subject Headings 2009; MeSH Blocking+Antibodies. Available at: http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?mode=&term=Blocking+Antibodies Accessed
-
- Bock F, Onderka J, Dietrich T, et al. Bevacizumab as a potent inhibitor of inflammatory corneal angiogensis and lymphangiogenesis. Invest Ophthalmol Vis Sci. 2007;48:2545–2552 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
